Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Grabbe

Showing results (41-50 of 325) with videos related to

Pageof 33
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 5, 2016
Checkpoint-Inhibitoren in der Immuntherapie: Ein Meilenstein in der Behandlung des malignen MelanomsSophia M Wilden, Berenice M Lang, Peter Mohr, et al.
Medizinische Klinik (Munich, Germany : 1983)|February 27, 2007
[Pictorial diagnosis. Calciphylaxis--a rare cause of leg ulcers]Kathrin Hölzle, Andreas Körber, Uwe Hillen, et al.
European Journal of Cell Biology|October 19, 2006
SWAP-70 associates transiently with macropinosomesPia Oberbanscheidt, Sandra Balkow, Jochen Kühnl, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 1, 2021
Significance of the pulsed dye laser in treatment of acral infantile hemangiomaUlrike Nikfarjam, Joanna Wegner, Stephan Grabbe, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 1, 2007
Side effects of HIV therapyStefan Esser, Doris Helbig, Uwe Hillen, et al.
Onkologie|October 11, 2013
Serum S100B levels correlate with clinical benefit in a metastatic melanoma patient treated by CTLA-4 blockade: a case reportCarmen Loquai, Tina Müller-Brenne, Simin Schadmand-Fischer, et al.
Future Oncology (London, England)|December 1, 2015
Radiotherapy with BRAF inhibitor therapy for melanoma: progress and possibilitiesSebastian Zahnreich, Arnulf Mayer, Carmen Loquai, et al.
Dermatologie (Heidelberg, Germany)|August 21, 2024
[Mycosis caused by Nannizzia incurvata in a traveler returning from Indonesia]Aikaterini Tsochataridou, Pietro Nenoff, Silke Uhrlaß, et al.
Dermatology (Basel, Switzerland)|February 20, 2003
Significant risk of a second melanoma in patients with a history of melanoma but no further predisposing factorsDorothee Nashan, Burak Kocer, Meinhard Schiller, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 5, 2016
Immune checkpoint inhibitors: a milestone in the treatment of melanomaSophia M Wilden, Berenice M Lang, Peter Mohr, et al.
Pageof 33

Showing results (41-50 of 325) with videos related to

Sort By:
Pageof 33
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 5, 2016
Checkpoint-Inhibitoren in der Immuntherapie: Ein Meilenstein in der Behandlung des malignen MelanomsSophia M Wilden, Berenice M Lang, Peter Mohr, et al.
Medizinische Klinik (Munich, Germany : 1983)|February 27, 2007
[Pictorial diagnosis. Calciphylaxis--a rare cause of leg ulcers]Kathrin Hölzle, Andreas Körber, Uwe Hillen, et al.
European Journal of Cell Biology|October 19, 2006
SWAP-70 associates transiently with macropinosomesPia Oberbanscheidt, Sandra Balkow, Jochen Kühnl, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 1, 2021
Significance of the pulsed dye laser in treatment of acral infantile hemangiomaUlrike Nikfarjam, Joanna Wegner, Stephan Grabbe, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 1, 2007
Side effects of HIV therapyStefan Esser, Doris Helbig, Uwe Hillen, et al.
Onkologie|October 11, 2013
Serum S100B levels correlate with clinical benefit in a metastatic melanoma patient treated by CTLA-4 blockade: a case reportCarmen Loquai, Tina Müller-Brenne, Simin Schadmand-Fischer, et al.
Future Oncology (London, England)|December 1, 2015
Radiotherapy with BRAF inhibitor therapy for melanoma: progress and possibilitiesSebastian Zahnreich, Arnulf Mayer, Carmen Loquai, et al.
Dermatologie (Heidelberg, Germany)|August 21, 2024
[Mycosis caused by Nannizzia incurvata in a traveler returning from Indonesia]Aikaterini Tsochataridou, Pietro Nenoff, Silke Uhrlaß, et al.
Dermatology (Basel, Switzerland)|February 20, 2003
Significant risk of a second melanoma in patients with a history of melanoma but no further predisposing factorsDorothee Nashan, Burak Kocer, Meinhard Schiller, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 5, 2016
Immune checkpoint inhibitors: a milestone in the treatment of melanomaSophia M Wilden, Berenice M Lang, Peter Mohr, et al.
Pageof 33